As UnitedHealth expands point-of-sale rebates, ICER evaluates rebate reform options

As the Trump administration moves to alter the rebate system so patients can share in negotiated savings, UnitedHealth is taking an incremental step in that direction under the existing system.

HHS proposed in January to scrap the rebates drug manufacturers pay PBMs and health plans in Medicare Part D, which could lead to lower list prices for some drugs and remove perverse incentives to steer patients to the most expensive drugs (see "Killing Part D Rebates")...